Xiufang Kong (Lindi Jiang, Jiang Lindi)

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 4

Top Topics

Rheumatoid Arthritis Patients

Chemotherapy Induced

Disease Activity

Coronary Artery

Top Venues

Therapeutic advances in chronic disease

International journal of rheumatic diseases

This page only lists publications with an associated author ORCID identifier.

Publications

Ji Zongfei, Zhang Lijuan, Sun Ying, Liu Dongmei, Wu Sifan, Kong Xiufang, Ma Lingying, Liu Yun, Ma Lili, Chen Huiyong, Xiufang Kong
Improved clinical outcomes of tocilizumab versus cyclophosphamide for IgG4-related disease: insights from a prospective IgG4-related disease registry. Therapeutic advances in chronic disease 12 (2021)
Xiaomin Dai, Xiaomeng Cui, Ying Sun, Lili Ma, Xiufang Kong
Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study. Therapeutic advances in chronic disease 11 (2020)
Chunling Wu, Ying Sun, Xiaomeng Cui, Sifan Wu, Lili Ma, Huiyong Chen, Yan Yan, Zongfei Ji, Yun Liu, Jiang Lin, Peng Lv, Rongyi Chen, Pingting Yang, Xiufang Kong
Effectiveness and safety of methotrexate versus leflunomide in 12-month treatment for Takayasu arteritis. Therapeutic advances in chronic disease 11 (2020)
Lili Ma, Wensu Yu, Xiaomin Dai, Mengmeng Yin, Yujiao Wang, Ying Sun, Xiufang Kong, Xiaomeng Cui, Sifan Wu, Zongfei Ji, Lingying Ma, Huiyong Chen, Jiang Lin, Lindi Jiang
Serum leptin, a potential predictor of long-term angiographic progression in Takayasu's arteritis. International journal of rheumatic diseases 22 (12) (2019)